Structural basis for strand-transfer inhibitor binding to HIV intasomes

Science. 2020 Feb 14;367(6479):810-814. doi: 10.1126/science.aay8015. Epub 2020 Jan 30.

Abstract

The HIV intasome is a large nucleoprotein assembly that mediates the integration of a DNA copy of the viral genome into host chromatin. Intasomes are targeted by the latest generation of antiretroviral drugs, integrase strand-transfer inhibitors (INSTIs). Challenges associated with lentiviral intasome biochemistry have hindered high-resolution structural studies of how INSTIs bind to their native drug target. Here, we present high-resolution cryo-electron microscopy structures of HIV intasomes bound to the latest generation of INSTIs. These structures highlight how small changes in the integrase active site can have notable implications for drug binding and design and provide mechanistic insights into why a leading INSTI retains efficacy against a broad spectrum of drug-resistant variants. The data have implications for expanding effective treatments available for HIV-infected individuals.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, N.I.H., Intramural

MeSH terms

  • Cryoelectron Microscopy
  • Drug Design
  • Drug Resistance, Viral*
  • HIV / chemistry
  • HIV / drug effects*
  • HIV Integrase / chemistry*
  • HIV Integrase Inhibitors / chemistry*
  • Heterocyclic Compounds, 4 or More Rings / chemistry*
  • Humans
  • Multiprotein Complexes / chemistry*
  • Multiprotein Complexes / genetics
  • Naphthyridines / chemistry
  • Nucleoproteins / chemistry*
  • Nucleoproteins / genetics
  • Virus Integration / drug effects

Substances

  • HIV Integrase Inhibitors
  • Heterocyclic Compounds, 4 or More Rings
  • Multiprotein Complexes
  • Naphthyridines
  • Nucleoproteins
  • bictegravir
  • HIV Integrase